Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial membrane components refer collectively to the molecular structures that make up the cytoplasmic/plasma/inner membranes as well as outer membranes in Gram-negative bacteria. The primary structural element is a **phospholipid bilayer** interspersed with proteins; this structure acts as a selective permeability barrier controlling entry and exit of substances[1][2][3]. In Gram-negative bacteria, an additional **outer membrane** contains unique components such as **lipopolysaccharide** ("endotoxin"), which plays roles in immune evasion and pathogenicity[5]. Membrane proteins mediate active transport, energy generation via proton motive force or electron transport chains, signal transduction, secretion systems for toxins/enzymes, and synthesis/export of cell wall precursors[1][2][3][4]. The composition varies between species but typically includes phospholipids with diverse fatty acid chains that modulate fluidity; some bacteria use hopanoids instead of sterols for stability[2][3]. The outer leaflet in Gram-negatives contains lipopolysaccharides critical for virulence. Membrane domains may exist with specialized functions such as protein recruitment or morphogenesis regulation[3][6]. Drugs like daptomycin disrupt the cytoplasmic/inner bacterial membranes by depolarization; polymyxins bind to LPS on outer membranes causing permeability changes—these mechanisms underlie their bactericidal activity but also pose toxicity risks due to potential effects on eukaryotic cells if selectivity is insufficient[6]. Note on correctness: "Bacterial membrane components" is not a single molecular target but rather refers broadly to multiple structural elements within bacterial envelopes. For structured data purposes it should be mapped more specifically—such as "Bacterial inner/cytoplasmic/plasma membrane," "Bacterial outer membrane," or individual targets like "Lipopolysaccharide"—depending on context.
Disruption of bacterial membrane integrity leading to leakage of cellular contents and cell death (e.g., daptomycin, polymyxins); Inhibition of lipid synthesis or function in the bacterial envelope (e.g., bacitracin)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial membrane component.